# Elizabeth Liz Canis

> Elizabeth Liz Canis is a Series B investor at Foresite Capital backing Medical and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Foresite Capital](https://shizune.co/investors/profile/foresite-capital)
- Total investments: 3
- Last investment: Sep 2025
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/elizabeth-canis

Elizabeth Liz Canis is a Series B investor at Foresite Capital focused on Medical and Health Care. Elizabeth Liz Canis

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series C | 1 | 33% |
| Series D | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Thyme Care | Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $97M | Series D | Sep 25, 2025 |  |
| Thyme Care | Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $55M | Series C | Jul 16, 2024 |  |
| Thyme Care | Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $60M | Series B | Aug 21, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [CVS Health Ventures](https://shizune.co/investors/profile/cvs-health-ventures) — VC Fund, 4 deals together
- [AlleyCorp](https://shizune.co/investors/profile/alleycorp) — VC Fund, 3 deals together
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 3 deals together
- [Frist Cressey Ventures](https://shizune.co/investors/profile/frist-cresseyventures) — VC Fund, 3 deals together
- [Town Hall Ventures](https://shizune.co/investors/profile/town-hall-ventures) — VC Fund, 3 deals together
- [Concord Health Partners](https://shizune.co/investors/profile/concord-health-partners) — VC Fund, 2 deals together

## About Foresite Capital

VC Fund · San Francisco, United States

Foresite Capital is a healthcare and life sciences investment firm. They take a data-driven approach to invest in startups that employ biology and big data to improve healthcare, such as 10x Genomics, Relay Therapeutics, Element Biosciences, and Inscripta.

5 contacts available at Foresite Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Dorothy Margolskee | Managing Director | https://shizune.co/investors/profile/dorothy-margolskee |
| James Tananbaum | Founder and CEO | https://shizune.co/investors/profile/jim-tananbaum |
| Stephen C. Peterson | Partner | https://shizune.co/investors/profile/stephen-c-peterson |
| Dennis D. Ryan | CFO & Managing Director | https://shizune.co/investors/profile/dennis-d-ryan |
| Elizabeth Liz Canis | Senior Advisor | https://shizune.co/investors/profile/elizabeth-liz-canis |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Elizabeth Liz Canis invest in?

Elizabeth Liz Canis invests primarily in Medical and Health Care startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Elizabeth Liz Canis last invest?

The most recent investment recorded for Elizabeth Liz Canis closed in Sep 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co